Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: Reuters Investment Profile
$20.00
Provider: Pechala's Reports
$15.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AstraZeneca PLC reaffirms FY 2017 revenue guidance-Conference Call


Thursday, 6 Feb 2014 02:00am EST 

AstraZeneca PLC:Expects FY 2017 revenues will be broadly in line with FY 2013.FY 2017 revenues of $23.46 bln - Thomson Reuters I/B/E/S. 

Company Quote

4741.0
30.0 +0.64%
21 Nov 2014